Tissue-targeted metabonomics: Biological considerations and application to doxorubicin-induced hepatic oxidative stress

Metabolomics

Volumn 5, Issue 2, 2009, Pages 219-228

  Price, Kristin E ^a   Larive, Cynthia K ^b   Lunte, Craig E ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anesthesia; Doxorubicin; Metabonomics; Microdialysis; NMR; Oxidative stress

Indexed keywords

ANIMALIA; RATTUS;

EID: 67349113790     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-008-0141-3     Document Type: Article

References (24)

1. Azaka, K., Nonami, T., Kurokawa, T., Kobayashi, H., Harada, A., Nakao, A., et al. (1996). Doxorubicin-induced disturbance of the energy metabolism after hepatectomy. The Journal of Surgical Research, 61, 454-458. doi: 10.1006/jsre.1996.0145.
2. Bagchi, D., Bagchi, M., Hassoun, E. A., Kelly, J., & Stohs, S. J. (1995). Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology, 95, 1-9. doi: 10.1016/0300-483X(94)02867-T.
3. Behnia, K., & Boroujerdi, M. (1999). Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats. The Journal of Pharmacy and Pharmacology, 51, 1275-1282. doi: 10.1211/0022357991777010.
4. 1H NMR spectroscopy of urine and pattern recognition. Analytical Biochemistry, 295, 194-202. doi: 10.1006/ abio.2001.5211.
5. Conklin, K. A. (2005). Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity. Integrative Cancer Therapies, 4, 110-130. doi: 10.1177/1534735405276191.
6. Cutler, R. G., Plummer, J., Chowdhury, K., & Heward, C. (2005). Oxidative stress profiling. Part II. Theory, technology, and practice. Annals of the New York Academy of Sciences, 1055, 136-158. doi: 10.1196/ annals.1323.031.
7. Davies, M. I., & Lunte, C. E. (1996). Simultaneous microdialysis sampling from multiple sites in the liver for the study of phenol metabolism. Life Sciences, 59, 1001-1013. doi: 10.1016/ 0024-3205(96)00407-9.
8. Deepa, P. R., & Varalakshmi, P. (2003). Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chemico-Biological Interactions, 146, 201-210. doi: 10.1016/j.cbi.2003.08.003.
9. Ganey, P. E., Kauffman, F. C., & Thurman, R. G. (1988). Oxygen-dependent hepatotoxicity due to doxorubicin: Role of reducing equivalent supply in perfused rat liver. Molecular Pharmacology, 34, 695-701.
10. Gavaghan, C. L., Nicholson, J. K., Connor, S. C., Wilson, I. D., Wright, B., & Holmes, E. (2001). Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague-Dawley rats. Analytical Biochemistry, 291, 245-252. doi: 10.1006/abio.2000.5034.
11. Khandelwal, P., Beyer, C. E., Lin, Q., McGonigle, P., Schechter, L. E., & Bach, A. C., II. (2004a). Nanoprobe NMR spectroscopy and in vivo microdialysis: New analytical methods to study brain neurochemistry. Journal of Neuroscience Methods, 133, 181-189. doi: 10.1016/ j.jneumeth.2003.10.012.
12. Khandelwal, P., Beyer, C. E., Lin, Q., Schechter, L. E., & Bach, A. C., II. (2004b). Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: A metabonomics approach. Analytical Chemistry, 76, 4123-4127. doi: 10.1021/ac049812u.
13. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. Journal of Pharmaceutical and Biomedical Analysis, 33, 1103-1115. doi: 10.1016/ S0731-7085(03)00410-2.
14. 2 uptake in periportal and pericentral regions of liver lobule: Stop-flow experiments with perfused liver. The American Journal of Physiology, 244, G656-G659.
15. Park, J. L., & Lucchesi, B. R. (1999). Mechanisms of myocardial reperfusion injury. The Annals of Thoracic Surgery, 68, 1905-1912. doi: 10.1016/S0003-4975(99)01073-5.
16. Plumb, R. S., Granger, J. H., Stumpf, C. L., Johnson, K. A., Smith, B. W., Gaulitz, S., et al. (2005). A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender, and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst (London), 130, 844-849. doi: 10.1039/ b501767j.
17. Price, K. E., Lunte, C. E., & Larive, C. K. (2008). Development of tissue-targeted metabonomics. Part 1. Analytical considerations. Journal of Pharmaceutical and Biomedical Analysis, 46, 737-747. doi: 10.1016/ j.jpba.2007.11.035.
18. Price, K. E., Vandaveer, S. S., Lunte, C. E., & Larive, C. K. (2005). Tissue targeted metabonomics: Metabolic profiling by microdialysis sampling and microcoil NMR. Journal of Pharmaceutical and Biomedical Analysis, 38, 904-909. doi: 10.1016/j.jpba.2005.02.034.
19. Saha, J. K., Xia, J., Grondin, J. M., Engle, S. K., & Jakubowski, J. A. (2005). Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: Mechanisms and implications for preclinical models. Experimental Biology and Medicine, 230, 777-784.
20. Singal, P. W., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N. (2000). Adriamycin-induced heart failure: Mechanism and modulation. Molecular and Cellular Biochemistry, 207, 77-85. doi: 10.1023/ A:1007094214460.
21. Tokarska-Schlattner, M., Wallimann, T., & Schlattner, U. (2006). Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. Comptes Rendus Biologies, 329, 657-668. doi: 10.1016/ j.crvi.2005.08.007.
22. Wang, Y., Wong, S. L., & Sawchuk, R. J. (1993). Microdialysis calibration using retrodialysis and zero-net flux: Application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharmaceutical Research, 10, 1411-1419. doi: 10.1023/ A:1018906821725.
23. Williams, R. E., Lenz, E. M., Evans, J. A., Wilson, I. D., Granger, J. H., Plumb, R. S., et al. (2005). A combined 1H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. Journal of Pharmaceutical and Biomedical Analysis, 38, 465-471. doi: 10.1016/j.jpba.2005.01.013.
24. Yokel, R. A., Allen, D. D., Burgio, D. E., & McNamara, P. J. (1992). Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis. Journal of Pharmacological and Toxicological Methods, 27, 135-142. doi: 10.1016/1056-8719(92)90034-X.